Friday, December 11, 2015

Pharmacology and Clinical Drug Candidates in Redox Medicine

›
V. Thao-Vi Dao, Ana I. Casas, Ghassan J. Maghzal, Tamara Seredenina, Nina Kaludercic, Natalia Robledinos-Anton, Fabio Di Lisa, Roland Stocke...
Thursday, December 10, 2015

Regulating biobanking with children’s tissue: a legal analysis and the experts’ view

›
Elcke J Kranendonk, M Corrette Ploem and Raoul C M Hennekam; European Journal of Human Genetics (2016) 24, 30–36; doi:10.1038/ejhg.2015.59; ...
Wednesday, December 9, 2015

Antioxidants in Translational Medicine.

›
Harald H.H.W. Schmidt, Roland Stocker, Claudia Vollbracht, Gøran Paulsen, Dennis Riley, Andreas Daiber and Antonio Cuadrado; Antioxid Redox ...
Tuesday, December 8, 2015

Friedreich Ataxia (Chapter 13)

›
Mary Kay Koenig, Chapter 13 - In Mitochondrial Case Studies, edited by Russell P. SanetoSumit ParikhBruce H. Cohen, Academic Press, Boston, ...
Monday, December 7, 2015

Analyzing the Effects of a G137V Mutation in the FXN Gene

›
Nathalie Faggianelli, Rita Puglisi, Liana Veneziano, Silvia Romano, Marina Frontali, Tommaso Vannocci, Silvia Fortuni, Roberto Testi and Ann...
Sunday, December 6, 2015

IFN-γ for Friedreich ataxia: present evidence.

›
McKenzie Wells, Lauren Seyer, Kimberly Schadt & David R Lynch; Neurodegenerative Disease Management, Posted online on December 4, 2015, ...
Friday, December 4, 2015

Systematic review and clinical recommendations for dosage of supported home-based standing programs for adults with stroke, spinal cord injury and other neurological conditions

›
Ginny Paleg and Roslyn Livingstone. BMC Musculoskelet Disord. 2015; 16: 358. Published online 2015 Nov 17. doi: 10.1186/s12891-015-0813-x ...
Wednesday, December 2, 2015

GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients.

›
Christian Marcotulli, Silvia Fortuni, Gaetano Arcuri, Barbara Tomassini, Luca Leonardi, Francesco Pierelli, Roberto Testi, Carlo Casali; Neu...
Tuesday, December 1, 2015

Dr Evans–Galea, a leader in the field of gene therapy, talks about the challenges she has faced, but also the increasing visibility of female scientists in her field, and her professional mission: finding a cure for Friedrich ataxia

›
www.theguardian.com, interview by Brigid Delaney, Tuesday 1 December The FXN gene was first discovered in the 90s, and there are potentia...

La phase de double appui : paramètre prédictif de la dégradation de la marche dans l’ataxie de Friedreich ?

›
B. Roche, R. Martin, I. Husson, Neurophysiologie Clinique/Clinical Neurophysiology, Volume 45, Issues 4–5, November 2015, Pages 403-404, ISS...